Bristol Gate Capital Partners Inc. lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 181,804 shares of the healthcare conglomerate's stock after selling 3,127 shares during the period. UnitedHealth Group accounts for 4.5% of Bristol Gate Capital Partners Inc.'s holdings, making the stock its 13th biggest holding. Bristol Gate Capital Partners Inc.'s holdings in UnitedHealth Group were worth $91,967,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in UNH. Employees Retirement System of Texas boosted its position in shares of UnitedHealth Group by 760.2% during the 4th quarter. Employees Retirement System of Texas now owns 238,512 shares of the healthcare conglomerate's stock valued at $120,654,000 after purchasing an additional 210,786 shares in the last quarter. Bell Asset Management Ltd raised its holdings in shares of UnitedHealth Group by 3.3% during the fourth quarter. Bell Asset Management Ltd now owns 28,496 shares of the healthcare conglomerate's stock valued at $14,415,000 after purchasing an additional 922 shares during the period. Sumitomo Mitsui Financial Group Inc. increased its position in UnitedHealth Group by 5.9% in the 4th quarter. Sumitomo Mitsui Financial Group Inc. now owns 44,174 shares of the healthcare conglomerate's stock valued at $22,346,000 after buying an additional 2,469 shares in the last quarter. Soundwatch Capital LLC boosted its holdings in UnitedHealth Group by 5.7% in the fourth quarter. Soundwatch Capital LLC now owns 1,922 shares of the healthcare conglomerate's stock worth $972,000 after acquiring an additional 104 shares in the last quarter. Finally, Ashburton Jersey Ltd grew its position in UnitedHealth Group by 4,457.9% in the 4th quarter. Ashburton Jersey Ltd now owns 12,762 shares of the healthcare conglomerate's stock valued at $6,456,000 after purchasing an additional 12,482 shares during the period. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
UNH stock opened at $524.94 on Monday. The stock's fifty day moving average price is $509.24 and its 200-day moving average price is $541.85. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $480.17 billion, a P/E ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same period last year, the firm earned $5.83 earnings per share. The business's quarterly revenue was up 6.8% on a year-over-year basis. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.
Insider Transactions at UnitedHealth Group
In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 0.33% of the company's stock.
Analysts Set New Price Targets
A number of research firms recently weighed in on UNH. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Barclays cut their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. Finally, Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $629.32.
Check Out Our Latest Report on UNH
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.